Drug intelligence / Profile preview

Sante FX V+

Development stage
Unknown
Lead developer
Santen Pharmaceutical
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

## Sante FX V+\nSante FX V+ is a Japanese over-the-counter ophthalmic combination drug developed and manufactured by Santen for symptomatic relief of eye fatigue and irritation. It is a multi-ingredient small-molecule eye drop containing pyridoxine hydrochloride, taurine, potassium L-aspartate, neostigmine methylsulfate, tetrahydrozoline hydrochloride, chlorpheniramine maleate, and epsilon-aminocaproic acid. The formulation combines nutritional and metabolic support components with a parasympathomimetic agent that can aid accommodative function, a vasoconstrictor that reduces conjunctival hyperemia, an antihistamine that reduces itching and irritation, and an anti-inflammatory or antifibrinolytic component used in ophthalmic irritation. It is marketed in Japan as a cooling eye drop for eye fatigue, conjunctival redness, itchy eyes, prevention of eye diseases, ocular inflammation caused by ultraviolet rays or other light exposure, blurred vision, blepharitis, and discomfort associated with hard contact lens use.

Brand names
Sante FX V+Sante FX V Plus
02

Targets

AcetylcholinesteraseADRA1A (α1A)HRH1 (Histamine H1 Receptor)ADRA1 (Alpha-1 adrenergic receptor family)

Beyond the preview

Go deeper on Sante FX V+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sante FX V+.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call